Guangyao Liu Selected Research

Guangyao Liu Research Topics

Disease

12	Neoplasms (Cancer) 03/2024 - 01/2017
6	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 03/2016
4	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2022
3	Osteonecrosis (Kienbock's Disease) 03/2022 - 09/2020
2	Glioma (Gliomas) 03/2024 - 10/2021
2	Wounds and Injuries (Trauma) 01/2022 - 09/2020
2	Trigeminal Neuralgia (Tic Douloureux) 01/2022 - 12/2021
1	Non-Muscle Invasive Bladder Neoplasms 11/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2023
1	Cicatrix (Scar) 02/2023
1	Paresthesia (Dysesthesia) 02/2023
1	Lymphatic Metastasis 01/2023
1	Osteomyelitis 01/2023
1	Comminuted Fractures 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Cognitive Dysfunction 01/2022
1	Adenocarcinoma 01/2022
1	Pain (Aches) 12/2021
1	Ascites 11/2021
1	Carcinogenesis 05/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Alcoholism (Alcohol Abuse) 09/2020
1	Osteoarthritis 01/2019
1	Tibial Plateau Fractures 06/2018
1	Idiopathic Generalized Epilepsy 01/2018
1	Juvenile Myoclonic Epilepsy 01/2018
1	Meningioma (Meningiomas) 05/2016
1	Hypoxia (Hypoxemia) 03/2016
1	Breast Neoplasms (Breast Cancer) 07/2015
1	Metabolic Diseases (Metabolic Disease) 05/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2015
1	Inflammation (Inflammations) 11/2014

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2014
4	Long Noncoding RNAIBA 10/2021 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2022
3	Competitive Endogenous RNAIBA 10/2021 - 12/2019
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
2	LipopolysaccharidesIBA 01/2022 - 01/2019
2	trans-crotonin (CTN)IBA 01/2022 - 12/2021
1	Protons (Proton)IBA 03/2024
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2024
1	MicellesIBA 12/2023
1	Catalytic DNA (Deoxyribozyme)IBA 12/2023
1	PorphyrinsIBA 12/2023
1	Singlet OxygenIBA 12/2023
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2023
1	Mitochondrial DNA (mtDNA)IBA 12/2023
1	Immunoconjugates (Immunoconjugate)IBA 11/2023
1	human ERBB2 proteinIBA 11/2023
1	Phosphates (Orthophosphate)IBA 11/2023
1	monomethyl auristatin EIBA 11/2023
1	Epirubicin (Ellence)FDA LinkGeneric 11/2023
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2023
1	UbiquitinIBA 01/2023
1	cephalomannineIBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	EnzymesIBA 01/2023
1	Collagen Type I (Type I Collagen)IBA 01/2023
1	atezolizumabIBA 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022
1	(+)-JQ1 compoundIBA 01/2022
1	SteroidsIBA 01/2022
1	Methylprednisolone FDA LinkGeneric 01/2022
1	IodineIBA 11/2021
1	RNA (Ribonucleic Acid)IBA 10/2021
1	Messenger RNA (mRNA)IBA 10/2021
1	MicroRNAs (MicroRNA)IBA 10/2021
1	PhosphoproteinsIBA 05/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	tideglusibIBA 01/2021
1	Glycogen Synthase KinasesIBA 01/2021
1	GlucocorticoidsIBA 09/2020
1	Circular RNAIBA 12/2019
1	Immunoglobulin E (IgE)IBA 01/2018
1	TropomyosinIBA 09/2017
1	Transcription Factor 4IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	AMP-Activated Protein KinasesIBA 03/2016
1	Acetyl-CoA CarboxylaseIBA 03/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2016
1	dorsomorphinIBA 03/2016
1	AICA ribonucleotide (ZMP)IBA 03/2016
1	gadobenic acid (gadobenate dimeglumine)FDA Link 07/2015
1	Bile Acids and Salts (Bile Acids)IBA 05/2015

Therapy/Procedure

9	Therapeutics 11/2023 - 05/2016
2	Drug Therapy (Chemotherapy) 01/2022 - 03/2016
1	Intravesical Administration 11/2023
1	Punctures 02/2023
1	Anesthesia 02/2023
1	Debridement 01/2023
1	Decompression 03/2022
1	Internal Fixators 01/2022
1	Hyperthermic Intraperitoneal Chemotherapy 01/2022
1	Intravenous Injections 01/2022
1	Injections 01/2022
1	Arthroplasty 09/2020
1	Anterior Cruciate Ligament Reconstruction 06/2018
1	Bariatric Surgery 05/2015